行情

SIGA

SIGA

SIGA Tech
NASDAQ

实时行情|Nasdaq Last Sale

5.28
+0.08
+1.54%
盘后: 5.28 0 0.00% 16:07 01/29 EST
开盘
5.19
昨收
5.20
最高
5.36
最低
5.19
成交量
15.23万
成交额
--
52周最高
7.17
52周最低
4.280
市值
4.28亿
市盈率(TTM)
8.51
分时
5日
1月
3月
1年
5年

SIGA 新闻

  • Hedge Funds Are Betting On SIGA Technologies Inc. (SIGA)
  • Insider Monkey.2019/12/19 23:08
  • 拼多多的最大护城河,靠得住吗?
  • 虎嗅网.2019/12/13 05:40
  • SIGA Announces Canadian Department Of National Defence Intent To Purchase Up To 15,325 Courses Of Oral TPOXX
  • Benzinga.2019/12/05 17:14
  • SIGA Announces Canadian Department of National Defence Intent to Purchase Up To 15,325 Courses of Oral TPOXX®
  • GlobeNewswire.2019/12/05 17:10

更多

所属板块

制药
+0.20%
制药与医学研究
+0.09%

热门股票

名称
价格
涨跌幅

SIGA 简况

SIGA Technologies, Inc. is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company's lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield). TPOXX is an investigational product that is not approved by the United States Food and Drug Administration (FDA) as a treatment of smallpox or any other indication. The Company relies on and uses third parties known as contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company identified a lead pre-clinical drug candidate with activity against four serotypes of the virus and which has shown efficacy in a murine model of disease.
展开

Webull提供SIGA Technologies, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。